Association among lifestyle, clinical examination, polymorphisms in CDH1 gene and Traditional Chinese Medicine syndrome differentiation of gastric cancer

Journal of Traditional Chinese Medicine

Volumn 33, Issue 5, 2013, Pages 572-579

  Zhang, Junfeng ^a   Zhan, Zhen ^a   Wu, Juan ^a   Zhang, Chunbing ^b   Yang, Yaping ^a   Tong, Shujuan ^a   Wang, Ruiping ^b   Yang, Xuewen ^b   Dong, Wei ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cadherins; Clinical examination; Polymorphism, single nucleotide; Stomach neoplasms; Syndrome differentiation

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC DNA; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CHINESE MEDICINE; CLINICAL EXAMINATION; COMPUTER PROGRAM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; POLYMERASE CHAIN REACTION; POPULATION; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TRADITIONAL MEDICINE;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84887765403     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(14)60023-6     Document Type: Article

References (36)

1. Terry M B, Gaudet M M, Gammon M D. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12(2): 111-127.
2. Nardone G, Compare D. Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Rev Gastroenterol Hepatol 2008; 2(2): 243-248.
3. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12(1): 17-20.
4. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362(9380): 305-315.
5. Wang J, Pan H F, Hu Y T, Zhu Y, He Q. Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis. Dig Dis Sci 2010; 55(7): 1818-1823.
6. Liu X P, Li P Q, Zhang W. Ideas and methods in preventing and treating peritoneal metastasis of gastric cancer by Traditional Chinese Medicine. Zhong Yi Za Zhi 2012; 53(4): 288-290.
7. Liu X, Hua B J. Effect of Traditional Chinese Medicine on quality of life and survival period in patients with progressive gastric cancer. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2008; 28(2): 592-594.
8. Bao H, Gao J, Huang T, Zhou Z M, Zhang B, Xia Y F. Relationship between Traditional Chinese Medicine syndrome differentiation and imaging characterization to the radiosensitivity of nasopharyngeal carcinoma. Chin J Cancer 2010; 29(11): 937-945.
9. LI P, Yang L P, Gong Y W. Application of systems biology technology in research of Traditional Chinese Medicine. J Tradit Chin Med 2009; 29(2): 153-157.
10. Sun D Z, Liu L, Jiao J P, Wei P K, Jiang L D, Xu L. Syndrome characteristics of Traditional Chinese Medicine: summary of a clinical survey in 767 patients with gastric cancer. Zhong Xi Yi Jie He Xue Bao 2010; 8(4): 332-340.
11. Forman D, Burley V J. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20(4): 633-649.
12. Yasui W, Oue N, Aung P P, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8(2): 86-94.
13. Wang D, Zhou J, Wang T, et al. Polymorphisms in MSH2 gene and risk of gastric cancer, and interactions with lifestyle factors in a Chinese population. Cancer Epidemiol 2012; 36(3): 171-176.
14. Shi J, Lu Y, Zhang X, et al. Relationship between expressions of estrogen and progesterone receptors and syndrome types of gastric carcinoma. Zhong Xi Yi Jie He Xue Bao 2010; 8(7): 629-635.
15. Chen W, OUyang X N, Lin Q C. Relationship between CD44v6 and TCM syndrome types of gastric carcinoma. Zhong Guo Zhong Xi Yi Jie He Wai Ke Za Zhi 2007; 13(3): 207-210.
16. Luo J Y, Nie R H, Zhu W. Gastric cancer patients with CEA, CA72-4 and Traditional Chinese Medicine syndrome types study. Jiangxi Zhong Yi Xue Yuan Xue Bao 2010; 22(2): 48-49.
17. Zhao L, Wang H B, Qi Y F. Relationship between Traditional Chinese Medicine syndrome types and the serum level of CEA. Shandong Zhong Yi Za Zhi 2011; 30(8): 541-542.
18. Xu L, Sun D Z, He J, Liu L, Wei P K. Expression of tumor metastasis-related gene protein in the same syndromic classification of gastric carcinoma on Traditional Chinese Medicine. Shi Jie Hua Ren Xiao Hua Za Zhi 2004; 12(12): 2782-2787.
19. Yang Y P, Wu J, Tong S J, et al. Syndrome description of gastric cancer-in terms of TCM syndrome differentiation. Shi Zhen Guo Yi Guo Yao 2012; 23(10): 2565-2567.
20. Zhan Z, Wu J, Zhang J F, et al. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Molecular Biology Reports 2012; 39(8): 8107-8113.
21. Jiang M, Lu C, Zhang C, et al. Syndrome differentiation in modern research of Traditional Chinese Medicine. J Ethnopharmacol 2012; 140:634-642.
22. Ji B T, Gao R N, Jin F, et al. A population-based case-control study of dietary factors and stomach cancer risk in Shanghai urban areas. Zhong Liu 1992; 12(5): 201-205.
23. Gao Y, Hua N, Han X Y, et al. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol 2011; 35(6): 91-99.
24. Zhou X B, Zhang J, Zhang C Y. Meta analysis of association between life habits and stomach cancer in Chinese people. Zhong Guo Lin Chuang Kang Fu 2006; 10(48): 10-13.
25. Ding J H, Li S P, Wu J Z, et al. Comparative study of gastric cancer risk factors between developed region and developing region in Jiangsu province. Zhong Guo Zhong Liu 2008; 17(2): 88-90.
26. Zhang J, Zhan Z, Wu J, et al. Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects. PLoS ONE 2013; 8(3): e59254.
27. Liu H Y, Dong Z N, Wang Y Q. Statistic analysis on activities of serum enzymes in patients with malignant tumor. Jun Yi Jin Xiu Xue Yuan Xue Bao 2007; 28(2): 145-146.
28. Anastasi J K, Currie L M, Kim G H. Understanding diagnostic reasoning in TCM practice: tongue diagnosis. Altern Ther Health Med 2009; 15(3): 18-28.
29. Mao D, Chen M X. Relationship between tongue image and gastric endoscopy in newly diagnosed patients with gastric cancer. Zhong Yi Yao Dao Bao 2011; 17(5): 17-19.
30. Wang X D, Qiao X T, Fan X L, Dou W L, Guo X Q. Clinical research on the relationship between TCM Tongue image and gastric endoscopy in the patients with gastric precancerous lesions. Jiangsu Zhong Yi Yao 2012; 44(9): 24-25.
31. Chen L Y, Lu G Z. Analysis of tongue images in 114 patients with gastric cancer. Zhong Yi Za Zhi 2011; 52(22): 1935-1938.
32. Zhang J F, Fan Y, Hao J F, et al. Gene expression in lingual mucous membranes with common tongue coatings obtained from cancer patients. J Chin Clin Med 2008; 3(6): 301-311.
33. Kangelaris K N, Gruber S B. Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer. JAMA 2007; 297(21): 2410-2411.
34. Berx G, Becker K F, Höfler H, Van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12(4): 226-237.
35. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007; 6(6): 832-839.
36. Oliveira C, Seruca R, Caldas C. Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 2003; 3(2): 201-215.